These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29470959)

  • 1. Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats.
    Kumar M; Wadhwa R; Kothari P; Trivedi R; Vohora D
    Eur J Pharmacol; 2018 Apr; 825():57-62. PubMed ID: 29470959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine treatment increases trabecular bone formation in mice.
    Battaglino R; Vokes M; Schulze-Späte U; Sharma A; Graves D; Kohler T; Müller R; Yoganathan S; Stashenko P
    J Cell Biochem; 2007 Apr; 100(6):1387-94. PubMed ID: 17041947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of escitalopram and carbidopa on bone markers in Wistar rats: a preliminary experimental study.
    Wadhwa R; Kumar M; Paudel YN; Iqbal R; Kothari P; Trivedi R; Vohora D
    J Bone Miner Metab; 2019 Jan; 37(1):36-42. PubMed ID: 29380075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.
    Nichols AL; Blumenfeld Z; Luebbert L; Knox HJ; Muthusamy AK; Marvin JS; Kim CH; Grant SN; Walton DP; Cohen BN; Hammar R; Looger L; Artursson P; Dougherty DA; Lester HA
    J Neurosci; 2023 Mar; 43(13):2222-2241. PubMed ID: 36868853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
    Dunham KE; Venton BJ
    J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP.
    Weaver SR; Fricke HP; Xie C; Lipinski RJ; Vezina CM; Charles JF; Hernandez LL
    Endocrinology; 2018 Aug; 159(8):2850-2862. PubMed ID: 29893816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram.
    Schreiber S; Pick CG
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):464-8. PubMed ID: 16413173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.
    Ortuño MJ; Robinson ST; Subramanyam P; Paone R; Huang YY; Guo XE; Colecraft HM; Mann JJ; Ducy P
    Nat Med; 2016 Oct; 22(10):1170-1179. PubMed ID: 27595322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
    Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antidepressant fluoxetine but not citalopram suppresses synapse formation and synaptic transmission between Lymnaea neurons by perturbing presynaptic and postsynaptic machinery.
    Getz A; Xu F; Zaidi W; Syed NI
    Eur J Neurosci; 2011 Jul; 34(2):221-34. PubMed ID: 21722207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake.
    Pinheiro IL; da Silva AI; Reginato A; da Silva Filho RC; Galindo LCM; Matos RJB; de Souza Ferraz JC; Toscano Meneses da Silva Castro AE; Milanski Ferreira M; Manhães de Castro R; de Souza SL
    Behav Brain Res; 2019 Jan; 357-358():65-70. PubMed ID: 28756214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
    Sánchez C; Gruca P; Papp M
    Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
    Ishima T; Fujita Y; Hashimoto K
    Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
    Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.
    Hansen CH; Larsen LW; Sørensen AM; Halling-Sørensen B; Styrishave B
    Toxicol In Vitro; 2017 Jun; 41():1-11. PubMed ID: 28179152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.